|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 405/14 | (2006.01) |
| A61P 11/00 | (2006.01) | ||
| A61K 31/4439 | (2006.01) |
| (11) | Patento numeris | 3523293 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17794779.3 |
| Europos patento paraiškos padavimo data | 2017-10-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2017/056196 |
| Data | 2017-10-06 |
| (87) | Numeris | WO 2018/065962 |
| Data | 2018-04-12 |
| (30) | Numeris | Data | Šalis |
| 201662405598 P | 2016-10-07 | US |
| (72) |
ALTENBACH, Robert J. , US
BOGDAN, Andrew , US
COUTY, Sylvain , FR
DE LEMOS, Elsa , FR
DESROY, Nicolas , FR
DUTHION, Béranger , FR
GFESSER, Gregory A. , US
GRESZLER, Stephen N. , US
HOUSSEMAN, Christopher Gaëtan , FR
KOENIG, John R. , US
KYM, Philip R. , US
LIU, Bo , US
SCANIO, Marc J. , US
SEARLE, Xenia , US
WANG, Xueqing , US
YEUNG, Ming C. , US
ZHAO, Gang , US
|
| (73) |
AbbVie Overseas S.à r.l. ,
26 Boulevard Royal, 2449 Luxembourg,
LU
Galapagos N.V. , Generaal de Wittelaan L11 A3, 2800 Mechelen, BE |
| (54) | SUBSTITUTED PYRROLIDINES AND THEIR USE IN THE TREATMENT OF CYSTIC FIIBROSIS |
| SUBSTITUTED PYRROLIDINES AND THEIR USE IN THE TREATMENT OF CYSTIC FIIBROSIS |